MMP9 Variation After Thrombolysis Is Associated With Hemorrhagic Transformation of Lesion and Death
Author(s) -
Domenico Inzitari,
Betti Giusti,
Patrizia Nencini,
Anna Maria Gori,
Mascia Nesi,
Vanessa Palumbo,
Benedetta Piccardi,
Alessandra Armillis,
Giovanni Pracucci,
Giorgio Bono,
Paolo Bovi,
Domenico Consoli,
Mario Guidotti,
Antonia Nucera,
Francesca Massaro,
Giuseppe Micieli,
Giovanni Orlandi,
Francesco Perini,
Rossana Tassi,
Maria Rosaria Tola,
Maria Sessa,
Danilo Toni,
Rosanna Abbate
Publication year - 2013
Publication title -
stroke
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.397
H-Index - 319
eISSN - 1524-4628
pISSN - 0039-2499
DOI - 10.1161/strokeaha.113.002274
Subject(s) - medicine , modified rankin scale , intracerebral hemorrhage , thrombolysis , odds ratio , stroke (engine) , confidence interval , tissue plasminogen activator , lesion , matrix metalloproteinase , gastroenterology , surgery , ischemia , ischemic stroke , myocardial infarction , subarachnoid hemorrhage , mechanical engineering , engineering
Experimentally, matrix metalloproteinases (MMPs) play a detrimental role related to hemorrhagic transformation and severity of an ischemic brain lesion. Tissue-type plasminogen activator (tPA) enhances such effects. This study aimed to expand clinical evidence in this connection.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom